We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Cannabis-based products for medicinal use will be available for specialist doctors to prescribe legally.
The ACMD has recommended that cannabis-derived medicinal products should be placed in Schedule 2 of the Misuse of Drugs Regulations 2001.
Specialist clinicians will be able to legally prescribe cannabis-derived medicinal products by the autumn, Home Secretary Sajid Javid announced today.
Sajid Javid announces review of the scheduling of cannabis
Patients prescribed cannabis-based medicines will be able to get their treatment in days rather than months.
SIA response to a Freedom of Information (FOI) request for confirmation of whether SIA licence-linked training covers the possession of medical cannabis.
Personal license applications received and granted for the importation of medicinal cannabis from October 2012 to October 2013.
Home Secretary to receive advice on cannabis-related medicinal products.
The importer and distributor of the above products (Eaststone Limited) has informed us of reports that two affected batches may be contaminated with mould.
A letter to clinicians from the Chief Medical Officer and NHS England following the rescheduling of legislation to allow the medicinal use of cannabis-based products.
The importer and distributor of the above products has informed us of reports that the microbial limit for Total Microbial Aerobic Count (TAMC) has been tested to exceed the predefined limit of 200 CfU/g as per the product specification fixed...
We released the following information on the purpose of the first ten cannabis licences granted in 2010 on 11th July 2011: Licenses are issued…
The Home Secretary today announced a review into the scheduling of cannabis for medicinal purposes.
An expert panel of clinicians set up to advise ministers on medicinal cannabis licence applications has started accepting applications.
The Medicines and Healthcare products Regulatory Agency has issued an opinion on the regulatory status of products containing CBD
Home Office Circular 006/2013 covers a change to the Misuse of Drugs Regulations 2001 and the Misuse of Drugs (Designation) Order 2001.
A framework for the assessment of the impact of rescheduling cannabis-based products for medicinal use (CBPMs).
Home Secretary responds to the recommendations of the Advisory Council on the Misuse of Drugs about scheduling of cannabis-derived medicinal products.
This circular draws attention to the contents of the Statutory Instrument (SI) – SI 2018/1055.
Home Secretary writes to the chair of the Advisory Council on the Misuse of Drugs about scheduling of cannabis-derived medicinal products.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey.